Litcius/Paper detail

Immune status could determine efficacy of COVID-19 therapies

Megan Cully

2020Nature Reviews Drug Discovery16 citationsDOIOpen Access PDF

Topics & Concepts

Immune systemClinical trialCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakImmunologyIntensive care medicineVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDrug-Induced Hepatotoxicity and Protection
Immune status could determine efficacy of COVID-19 therapies | Litcius